RENEE BAKER: Open Payments
NPI 1528443264 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,427 in 98 payments from 35 companies in 2025. Trend: 2023 $16 · 2024 $1,355 · 2025 $2,427
Food & beverage: $2,104Education: $323
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $225 |
| AstraZeneca Pharmaceuticals LP | 12 | $220 |
| ABBVIE INC. | 8 | $171 |
| Merck Sharp & Dohme LLC | 8 | $170 |
| Novocure Inc. | 1 | $143 |
| Daiichi Sankyo Inc. | 2 | $121 |
| Myriad Genetic Laboratories, Inc. | 1 | $105 |
| SEAGEN INC. | 1 | $100 |
| Janssen Biotech, Inc. | 5 | $93 |
| Incyte Corporation | 5 | $90 |
Products named: ENHERTU, KEYTRUDA, Optune Lua (NovoTTF-200T), ELAHERE, KISQALI, SARCLISA, MYRISK, PLUVICTO.
Industry payments across MO — which companies pay providers there.
